Site map
  • News
  • News
  • Front Page
  • Structure and Contacts
  • About us
    Director
    Contact information
    Quality policy and objectives
  • Annual Reports
  • Legislation
  • All legislation
  • Marketing Authorisation
  • Fees
    E-submission
    Authorisation procedures
    Summary product characteristic, labelling, package leaflet
    Variation procedures
    Parallel import
    Common Procedures
    Areas of special competence
    Advice to applicants and pre-submission meetings
  • Clinical Trials
  • Licensing of pharmaceutical activity
  • Licensing of Pharmaceutical Activity of Legal Entities (enterprises)
    Licences for activity with narcotic and psychotropic substances
    Sizes of state fees
    Applications for obtaining a licence
    Statistical data
  • Supervision of manufacturing and distribution
  • Rapid Alerts
    Suspected Quality Defects in Medicinal Products
  • Pharmacovigilance
  • Register of Medicinal Products
  • Links
  • Lithuanian PRESIDENCY 2013
  • News title
    The Second Steering Committee Meeting of the EU-funded Twinning project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity”
    2017-06-29

    On 20th June 2017, the second Steering Committee meeting of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was held for reviewing the progress made under the project.

    --->
    The first Steering Committee of the EU-funded Twinning project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” has been
    2017-04-11

    On April 4th, 2017, in Republic of Moldova the first Steering Committee Meeting of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” was held for the purpose of reviewing the progress made under the project as well as to discuss results achieved and problems occurred. The Project Steering Committee also discussed the draft of the 1st Quarterly Report for the period 12 December 2016 – 31 March 2017.

    --->
    With EU support a new Twinning project in the area of medicines and medical devices is launched
    2017-03-14

    The formal opening ceremony organised on 9 March 2017 by the Delegation of the European Union to the Republic of Moldova, the Medicines and Medical Devices Agency of the Republic of Moldova, the State Medicines Control Agency under the Ministry of Health of the Republic of Lithuania and the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of the Republic of Poland marked the official start of the EU-funded Twinning project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” which will strive to improve the quality of the medicines, medical devices and pharmaceutical activity in the Republic of Moldova.

    --->
    Regarding medicinal products for which „sunset clause“ may already be applied
    2017-02-23

    The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.

    --->
    Cardiovascular system medicines – the most consumed in all Baltic States
    2016-10-26

    The most consumed medicines in the Baltic States from 2013 to 2015 were medicines used to treat cardiovascular system diseases similar as during the period from 2010 to 2012, shows the new book “Baltic Statistics on Medicines 2013–2015”. The consumption of these medicines more than threefold exceeded the consumption of the second most used groups of medicines in each of the Baltic States (the group of alimentary tract and metabolism medicines in Latvia and Estonia and the nervous system medicines in Lithuania).

    --->